Consistently, similar results were obtained from RNA sequencing analysis after knocking down SLC7A1 in meningioma cells, further suggesting the potential oncogenic role of SLC7A1 in meningioma through the regulation of E2F targets, G2M checkpoint, and MYC targets pathways. This evidence concerns the gene MYC and meningioma.